Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ENDRA Life Sciences Inc. - Common Stock (NQ:NDRA)

3.958 -0.042 (-1.04%)
Streaming Delayed Price Updated: 9:31 AM EST, Jan 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ENDRA Life Sciences Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
ENDRA Life Sciences Achieves Key Quality Management System Certification
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences: Q4 Earnings Insights ↗
ENDRA Life Sciences (NASDAQ:NDRA) reported its Q4 earnings results on Wednesday, March 30, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings ENDRA Life Sciences... 
Via Benzinga
News headline image
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Protection with Issuance of 10th and 11th Chinese Patents
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
During Monday's session, 291 companies made new 52-week lows. Also check out this: Insiders Buying These 4 Penny Stocks Noteable 52-Week Lows And Highs: SAP (... 
Via Benzinga
News headline image
Earnings Scheduled For March 30, 2022 ↗
Companies Reporting Before The Bell • Orgenesis (NASDAQ:ORGS) is likely to report earnings for its fourth quarter. • RumbleON (NASDAQ:RMBL) is estimated to report earnings for its Fiscal Year 2021. 
Via Benzinga
News headline image
Earnings Preview: ENDRA Life Sciences ↗
ENDRA Life Sciences (NASDAQ:NDRA) is set to give its latest quarterly earnings report on Wednesday, 2022-03-30. Here's what investors need to know before the announcement. Analysts estimate that ENDRA... 
Via Benzinga
News headline image
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets. 
Via Benzinga
News headline image
ENDRA Life Sciences to Report Fourth Quarter 2021 Financial Results on March 30, 2022
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Gainers CVRx (NASDAQ:CVRX) shares rose 11.6% to $7.2 during Friday's after-market session. The market value of their outstanding shares is at $156.2 million. 
Via Benzinga
News headline image
The Stock Day Podcast Hosted ENDRA Life Sciences Inc. to Discuss the Potential of its Thermo Acoustic Enhanced UltraSound (TAEUS(R))
Phoenix, Arizona--(Newsfile Corp. - February 15, 2022) - The Stock Day Podcast welcomed ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("the... 
Via Newsfile
News headline image
25 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 52.8% to $0.65 in pre-market trading after declining 6% on Friday. TC BioPharm (Holdings) plc (NASDAQ: TCBP)... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.6% to $1.35 during Friday's regular session. As of 12:30 EST, Dermata Therapeutics's stock is... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock rose 29.0% to $1.38 during Friday's pre-market session. The company's market cap stands at $11.4 million. Innoviva... 
Via Benzinga
News headline image
ENDRA Life Sciences Strengthens TAEUS® System Global Intellectual Property Portfolio with Issuance of 6th and 7th European Patents
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Gainers Dermata Therapeutics (NASDAQ:DRMA) shares moved upwards by 26.1% to $1.35 during Thursday's regular session. The current volume of 17.5 million shares is 7266.... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Gainers Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 27.1% to $1.36 during Thursday's pre-market session. The company's market cap stands at $11.3... 
Via Benzinga
News headline image
62 Biggest Movers From Yesterday ↗
Gainers American Rebel Holdings, Inc. (NASDAQ: AREB) shares jumped 42.8% to close at $3.07 on Thursday following the company's recent uplisting to the Nasdaq.... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning, trader! Rub that sleep out our your eyes because we're going over the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
News headline image
Stocks That Hit 52-Week Lows On Thursday ↗
On Thursday, 89 companies hit new 52-week lows. Noteable 52-Week Lows: The company with the largest market cap to set a new 52-week low was Seagen (NASDAQ:SGEN).... 
Via Benzinga
News headline image
ENDRA Life Voluntarily Withdraws 510(k) Application For Liver Fat Measuring System ↗
ENDRA Life Sciences Inc (NASDAQ: NDRA) plans to voluntarily withdraw its 510(k) application, currently under FDA review for its TAEUS System. Instead, the Company will... 
Via Benzinga
News headline image
ENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS® System
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Expands into China with Shanghai General Hospital Partnership
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences to Present at the H.C. Wainwright BioConnect Virtual Conference
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Announces New Clinical Study Partnership with King’s College Hospital, London
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
ENDRA Life Sciences Expands Pharmaceutical Partnerships with VGI Health Technology to Provide TAEUS for Patient Screening and Biomarker Measurement for Phase 2 Study
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Gainers Rani Therapeutics Hldgs (NASDAQ:RA... 
Via Benzinga
News headline image
ENDRA Life Sciences Further Strengthens TAEUS® System Intellectual Property with Issuance of 22nd and 23rd U.S. Patents
From ENDRA Life Sciences Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Kezar Life Sciences (NASDAQ:KZR) stock rose 48.27% to $12.47 during Tuesday's pre-market session. The market value of their outstanding shares is at $612.8... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Kezar Life Sciences Reports Positive Interim Phase 2 Data For Lupus Nephritis... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.